Lesley E. Wallace

1.9k total citations
25 papers, 1.6k citations indexed

About

Lesley E. Wallace is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Lesley E. Wallace has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 14 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Lesley E. Wallace's work include Immune Cell Function and Interaction (18 papers), Viral-associated cancers and disorders (14 papers) and T-cell and B-cell Immunology (10 papers). Lesley E. Wallace is often cited by papers focused on Immune Cell Function and Interaction (18 papers), Viral-associated cancers and disorders (14 papers) and T-cell and B-cell Immunology (10 papers). Lesley E. Wallace collaborates with scholars based in United Kingdom, Sweden and India. Lesley E. Wallace's co-authors include Alan B. Rickinson, M. A. Epstein, Martin Rowe, Denis J. Moss, Riccardo Gavioli, Pedro O. de Campos‐Lima, Riccardo Dolcetti, Maria G. Masucci, David Rowe and Gérard I. Evan and has published in prestigious journals such as Nature, Science and The EMBO Journal.

In The Last Decade

Lesley E. Wallace

25 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lesley E. Wallace United Kingdom 17 1.1k 889 556 448 327 25 1.6k
I S Misko Australia 27 1.5k 1.4× 1.6k 1.8× 934 1.7× 515 1.1× 376 1.1× 49 2.6k
M Heller United States 21 1.0k 1.0× 462 0.5× 526 0.9× 464 1.0× 486 1.5× 29 1.7k
S. Finerty United Kingdom 22 948 0.9× 361 0.4× 460 0.8× 473 1.1× 358 1.1× 36 1.3k
Linda Tan United Kingdom 9 648 0.6× 1.2k 1.4× 548 1.0× 180 0.4× 167 0.5× 11 1.7k
J Devriès United States 5 421 0.4× 621 0.7× 339 0.6× 106 0.2× 115 0.4× 9 1.1k
E. Beth United States 14 878 0.8× 263 0.3× 476 0.9× 383 0.9× 223 0.7× 26 1.3k
Misako Yajima Japan 15 566 0.5× 458 0.5× 365 0.7× 223 0.5× 151 0.5× 25 1.1k
Lee Heston United States 24 2.5k 2.3× 414 0.5× 1.3k 2.3× 827 1.8× 1.1k 3.2× 42 2.7k
Norbert Kienzle Australia 23 457 0.4× 604 0.7× 190 0.3× 130 0.3× 166 0.5× 43 1.2k
Jamie Wilson United Kingdom 10 536 0.5× 1.5k 1.7× 593 1.1× 161 0.4× 388 1.2× 12 2.1k

Countries citing papers authored by Lesley E. Wallace

Since Specialization
Citations

This map shows the geographic impact of Lesley E. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley E. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley E. Wallace more than expected).

Fields of papers citing papers by Lesley E. Wallace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley E. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley E. Wallace. The network helps show where Lesley E. Wallace may publish in the future.

Co-authorship network of co-authors of Lesley E. Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley E. Wallace. A scholar is included among the top collaborators of Lesley E. Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley E. Wallace. Lesley E. Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Steven P., Lesley E. Wallace, Michael Mackett, et al.. (1993). MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways. International Immunology. 5(5). 451–460. 9 indexed citations
2.
Gavioli, Riccardo, Michael G. Kurilla, Pedro O. de Campos‐Lima, et al.. (1993). Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. Journal of Virology. 67(3). 1572–1578. 146 indexed citations
3.
Madej, Monika, Andrew Morgan, Lesley E. Wallace, et al.. (1992). Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector system. Vaccine. 10(11). 777–782. 16 indexed citations
4.
Wallace, Lesley E., John Wright, David Ulaeto, Andrew Morgan, & Alan B. Rickinson. (1991). Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones. Journal of Virology. 65(7). 3821–3828. 44 indexed citations
5.
Kennedy, L. J., Lesley E. Wallace, J. Alejandro Madrigal, Alan B. Rickinson, & Julia G. Bodmer. (1987). New HLA-A2 variants defined by monoclonal antibodies and cytotoxic T lymphocytes. Immunogenetics. 26(3). 155–160. 9 indexed citations
6.
Rowe, David, Martin Rowe, Gérard I. Evan, et al.. (1986). Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.. The EMBO Journal. 5(10). 2599–2607. 175 indexed citations
7.
Wallace, Lesley E., L. J. Kennedy, Carol S. Landon, J. G. Bodmer, & A. B. Rickinson. (1986). Functional analysis of the HLA‐A2/Aw68 recombinant molecule HLA‐Aw69: Epstein‐Barr virus specific cytotoxic T cells restricted through Aw69 can utilise restricting determinants on Aw68 but not on A2. Tissue Antigens. 27(5). 298–307. 5 indexed citations
8.
Rooney, Cliona M., Martin Rowe, Lesley E. Wallace, & Alan B. Rickinson. (1985). Epstein–Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance. Nature. 317(6038). 629–631. 108 indexed citations
9.
Gotch, Frances, Shirley A. Ellis, Lesley E. Wallace, et al.. (1985). Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity. Immunogenetics. 21(1). 11–23. 32 indexed citations
10.
Wallace, Lesley E., et al.. (1985). Allospecific T cell recognition of HLA-A2 antigens: Evidence for group-specific and subgroup-specific epitopes. Immunogenetics. 21(3). 201–214. 10 indexed citations
11.
Rickinson, Alan B., Q. Y. Yao, & Lesley E. Wallace. (1985). THE EPSTEIN–BARR VIRUS AS A MODEL OF VIRUS–HOST INTERACTIONS. British Medical Bulletin. 41(1). 75–79. 64 indexed citations
12.
Gaston, J. S. Hill, Lesley E. Wallace, Alan B. Rickinson, M. A. Epstein, & Donald Pious. (1984). Mutant HLA-A2 antigens as restricting elements for virus-specific cytotoxic T cells. Immunogenetics. 19(6). 475–486. 9 indexed citations
13.
Wallace, Lesley E., A. B. Rickinson, Martin Rowe, & M. A. Epstein. (1982). Epstein–Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen. Nature. 297(5865). 413–415. 90 indexed citations
14.
Wallace, Lesley E., Alan B. Rickinson, Martin Rowe, et al.. (1982). Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. Cellular Immunology. 67(1). 129–140. 54 indexed citations
15.
Wallace, Lesley E., Martin Rowe, Hill Gaston, Alan B. Rickinson, & M. A. Epstein. (1982). Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. III. Establishment of HLA‐restricted cytotoxic T cell lines using interleukin 2. European Journal of Immunology. 12(12). 1012–1018. 58 indexed citations
16.
Moss, Denis J., Lesley E. Wallace, Alan B. Rickinson, & M. A. Epstein. (1981). Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro. European Journal of Immunology. 11(9). 686–693. 78 indexed citations
17.
Rickinson, Alan B., Denis J. Moss, Lesley E. Wallace, et al.. (1981). Long-term T-cell-mediated immunity to Epstein-Barr virus.. PubMed. 41(11 Pt 1). 4216–21. 183 indexed citations
18.
Wallace, Lesley E., Denis J. Moss, Alan B. Rickinson, Andrew J. McMichael, & M. A. Epstein. (1981). Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants. European Journal of Immunology. 11(9). 694–699. 60 indexed citations
19.
Moss, Denis J., Alan B. Rickinson, Lesley E. Wallace, & M. A. Epstein. (1981). Sequential appearance of Epstein–Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation. Nature. 291(5817). 664–666. 50 indexed citations
20.
Rickinson, Alan B., Lesley E. Wallace, & M. A. Epstein. (1980). HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cells. Nature. 283(5750). 865–867. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I S Misko Breakdown of academic impact, for papers by M Heller Breakdown of academic impact, for papers by S. Finerty Breakdown of academic impact, for papers by Linda Tan Breakdown of academic impact, for papers by J Devriès Breakdown of academic impact, for papers by E. Beth Breakdown of academic impact, for papers by Misako Yajima Breakdown of academic impact, for papers by Lee Heston Breakdown of academic impact, for papers by Norbert Kienzle Breakdown of academic impact, for papers by Jamie Wilson
Rankless by CCL
2026